Contributing to the Functional Classification of Missense Variants in RAG1 Protein from Structural Perspective

Abstract

Objective: Primary immune deficiencies (PIDs) are syndromic diseases characterized by severe clinical f indings in early childhood. The diagnosis and treatment of PID are challenging due to its genetic and clinical heterogeneity. Severe combined immune deficiency (SCID) is one of its most severe and fatal forms and is characterized by the absence of T lymphocytes and either the presence of B and/or natural killer (NK) cells. The failures in variable, diversity, joining (V(D)J) recombination, which are also controlled by the recombination activating gene (RAG) 1/2 complex, result in the deficiency of B- and T-cells, and these failures are associated with SCID or its alternative forms. Due to complete defect in RAG1 function, the SCID phenotype occurs, but OMENN syndrome (OS) and atypic SCID (AS) occur if defects in RAG1 function are partially tolerated. Materials and Methods: By using in-silico computational tools, the structural differences are revealed and then variants are prioritized according to how degree the existing structural alterations are tolerated or not. Results: These promising ones are Arg474Cys, Arg778Gln & Arg975Trp in AS, Arg396His, Arg396Leu, Arg624Cys, Trp552Cys, Val433Met & Met435Val in OS, and Arg474His and Glu722Lys in SCID. Conclusions: The utilization of in-silico computational tools provides a great advantage to gain insight about variant specific molecular mechanisms of diseases to boost existing knowledge about RAG1/2 failures.

Keywords

• Primer immune deficiency
• Severe combined immunodeficiency
• Omenn syndrome
• Atypical SCID
• RAG1 gene
• Structural alterations

References

1. 1. Marti LC, Bacal NS, Bento LC, Correia RP, Rocha FA. Lymphoid Hematopoiesis and Lymphocytes Differentiation and Maturation. Gheorghita İsvaronu, editors. Lymphocyte Updates: Cancer, Autoimmunity and İnfectious. Crotatia: İntect; Open; 2007. p: 1-32 google scholar
2. 2. Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: Severe immunodeficiency with a spectrum of clinical presentations. Blood 2001; 97(1): 81-8. google scholar
3. 3. Lewis SM. The mechanism of V(D)J joining: Lessons from molecular, immunological, and comparative analyses. Adv İmmunol 1994; 56: 27-150. google scholar
4. 4. Kim MS, Chuenchor W, Chen X, Cui Y, Zhang X, Zhou ZH, et al. Cracking the DNA code For V(D)J recombination. Mol Celi 2018; 70(2): 358-70 google scholar
5. 5. Gennery A. Recent advances in understanding RAG deficiencies. F1000Research 2019; 8: F1000 Faculty Rev-148. google scholar
6. 6. Spanopoulou E, Zaitseva F, Wang FH, Santagata S, Baltimore D, Panayotou G. The homeodomain region oF Rag-1 reveals the parallel mechanisms oF bacterial and V(D)J recombination. Cell 1996; 87 (2): 263-76 google scholar
7. 7. Lawless D, Lango Allen H, Thaventhiran J, NİHR BioResource-Rare Diseases Consortium, Hodel F, Anwar R, et al. Predicting the occurrence oF variants in RAG1 and RAG2. J Clin İmmunol 2019; 39(7): 688-701. google scholar
8. 8. Pasic S, Djuricic S, Ristic G, Slavkovic B. Recombinase-activating gene 1 immunodeficiency: DiFFerent immunological phenotypes in three siblings. Acta Paediatr İnt J Paediatr 2009; 98(6): 1062-64. google scholar

9. 9. Notarangelo LD, Kim MS, Walter JE, Lee YN. Human RAG mutations: Biochemistry and clinical implications. Nat Rev İmmunol 2016; 16: 234-46 google scholar
10. 10. Ru H, Chambers MG, Fu TM, Tong AB, Liao M, Wu H. Molecular mechanism oF V(D)J recombination From synaptic RAG1-RAG2 complex structures. Cell 2015; 163 (5): 1138-52. google scholar
11. 11. Gellert M. V(D)J recombination: RAG proteins, repair Factors, and regulation. Annu Rev Biochem 2002; 71: 101-32. google scholar
12. 12. Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 14(1): 28-33. google scholar
13. 13. Craig DB, Dombkowski AA. Disulfide by Design 2.0: A web-based tool For disulfide engineering in proteins. BMC BioinFormatics 2013; 14: 340-6. google scholar
14. 14. Khanna T, Hanna G, Sternberg MJE, David A. Missense3D-DB web catalogue: an atom-based analysis and repository oF 4M human protein-coding genetic variants. Hum Genet 2021; 140(5): 805-12. google scholar
15. 15. Vohra S, Biggin PC. Mutationmapper: A tool to aid the mapping oF protein mutation data. PLoS One 2013; 8(8): e71711. google scholar
16. 16. İJspeert H, Driessen G J, Moorhouse M J, Hartwig NG, Wolska-Kusnierz B, Kalwak K et al. Similar recombination-activating gene (RAG) mutations result in similar immunobiological eFFects but in diFFerent clinical phenotypes. J Allergy Clin İmmunol 2014; 133(4): 1124-33. google scholar
17. 17. Mo X, Bailin T, SadoFsky MJ. RAG1 and RAG2 cooperate in specific binding to the recombination signal sequence in vitro. J Biol Chem 1999; 274(11): 7025-31. google scholar
18. 18. Makhatadze Gİ, Loladze V V., Ermolenko DN, Chen XF, Thomas ST. Contribution oF surFace salt bridges to protein stability: Guidelines For protein engineering. J Mol Biol 2003; 327(5): 1135-48 google scholar
19. 19. Anderson DE, Becktel WJ, Dahlquist FW. pH-induced denaturation oF proteins: A single salt bridge contributes 3-5 kcal/mol to the Free energy oF Folding oF T4 lysozyme. Biochemistry 1990; 29(9): 2403-08. google scholar
20. 20. Gwyn LM, Peak MM, De P, Rahman NS, Rodgers KK. A Zinc site in the C-terminal domain oF RAG1 is essential For DNA cleavage activity. J Mol Biol 2009; 390: 863-78. google scholar
21. 21. Matthews AG, Kuo AJ, Ramön-Maiques S, Han S, Champagne KS, Ivanov D, et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 2007; 450(7172): 1106-10 google scholar
22. 22. Kuo TC, Schlissel MS. Mechanisms controlling expression oF the RAG locus during lymphocyte development. Curr Opin Immunol 2009; 21(2): 173-8. google scholar
23. 23. Gomez CA, Ptaszek LM, Villa A, Bozzi F, Sobacchi C, Brooks EG, et al. Mutations in conserved regions oF the predicted RAG2 kelch repeats block initiation oF V ( D ) J recombination and result in primary immunodeficiencies 2000; 20(15): 5653-64. google scholar